Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-12FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
FDA approved a supplemental application for Synagis (palivizumab) from Swedish Orphan Biovitrum AB, indicating an approved change to the pro…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression [Phase 1]
A Phase 1 trial from GlaxoSmithKline evaluated Danirixin (GSK1325756) for its ability to inhibit CD11b cell surface expression in the settin…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Specific Respiratory Infections as Triggers of Acute Medical Events
A completed clinical trial update examining whether specific respiratory infections act as triggers for acute medical events, including card…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®
Clinical trial update for Synagis Liquid 50mg and 100mg for intramuscular injection in immunocompromised children with Respiratory Syncytial…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [Phase 1]
Phase 1 trial update reporting safety and immune response data for a live-attenuated Respiratory Syncytial Virus vaccine in RSV-seronegative…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Idylla IFV-RSV Panel Clinical Testing
Clinical trial NCT02786381 assessing the Idylla IFV-RSV Panel for detecting influenza and RSV completed testing with Janssen as sponsor.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers [Phase 1]
This Phase 1 trial evaluated the safety, tolerability and immunogenicity of two RSV vaccine candidates, Ad26.RSV.FA2 followed by Ad35.RSV.FA…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults [Phase 1]
Phase 1 study evaluating the safety of the RSV vaccine MEDI7510 in older adults has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections
A Janssen-sponsored clinical trial in Belgian children hospitalized with RSV-related acute respiratory infections has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [Phase 1]
Phase 1 clinical trial assessing the safety and immune response of a single-dose Respiratory Syncytial Virus vaccine in RSV-seronegative inf…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis
Observational program evaluating hospitalization rates for respiratory syncytial virus in high-risk children who received palivizumab prophy…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age [Phase 1]
Phase I randomized, observer-blinded, dose-ranging study of an RSV vaccine in healthy children aged 24 to under 72 months completed.
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections. [Phase 1]
Phase 1 trial of the RSV001 vaccine to prevent severe respiratory syncytial virus infections has completed.
-
FDA approval · 2016-01-06FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ribavirin from Aurobindo Pharma Limited, authorizing continued approval and use of the ribavirin…
-
FDA approval · 2016-01-06FDA Approved: VIRAZOLE — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for Virazole (ribavirin) submitted by Bausch Health US, LLC, resulting in labeling changes as part o…
-
CLINICAL_TRIALS research · 2015-12-28Clinical Trial Update: Residual Sample Collection for Respiratory Viral Panel
This completed clinical trial update reports residual sample collection for a respiratory viral panel evaluating influenza A/B, respiratory …
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Safety, Tolerability and PK Study of AK0529 in Healthy Human [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of AK0529 in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections
A completed clinical trial update involving Japanese children hospitalized with RSV-related lower respiratory tract infections. The study co…
-
CLINICAL_TRIALS research · 2015-08-11Clinical Trial Update: A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa
Update on an observational household cohort study in South Africa examining the burden and transmission dynamics of influenza, respiratory s…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Surveillance of Synagis in Korean Pediatric Patients
A completed surveillance trial examining palivizumab (Synagis) use in Korean pediatric patients for respiratory syncytial virus infection, w…
-
CLINICAL_TRIALS research · 2015-01-14Clinical Trial Update: Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)
A prospective multicenter study in Turkish NICUs investigated Respiratory Syncytial Virus infections and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America
A one-year observational study of Palivizumab in infants at risk for respiratory syncytial virus infection in Latin America has been complet…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
An observational study evaluating RSV-associated illness in adults with COPD and/or congestive heart failure has completed.
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. [NA]
This clinical trial update examines whether a short intervention during respiratory syncytial virus prophylaxis affects influenza vaccinatio…
-
FDA approval · 2014-03-21FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
The FDA approved a supplemental application for Synagis (palivizumab) submitted by Swedish Orphan Biovitrum AB (publ).